June 1st, on the festive day of International Children's Day, it is also the time when gene editing drugs are launched in Denmark for a month and a half.

All kinds of newspapers and media, big and small in Denmark, are reporting on something shocking!

【The magical drug from China, treating cancer is no longer a fantasy】

【Cancer gene editing drugs: the savior of cancer patients】

[Denmark becomes the world's first country to market cancer gene editing drugs!]

[Denmark is at the forefront of cancer treatment!]

One and a half months after Ruikang Medical's cancer gene editing drug was treated for 28,600 Danish cancer patients one and a half months later, and the effect was very good!

Denmark cancer patients are mainly lung cancer, bronchial cancer, intestinal cancer, etc. that are related to respiratory, and can all receive cancer gene editing drug treatment. Only a few patients with skin cancer cannot participate.

In addition, Denmark implements a medical system that is one of the most perfect countries in the world. 9.8% of the tax is used to build medical care every year. Medical services are particularly developed and are basically free for all people. Therefore, with the promotion of the government, most cancer patients quickly went to the hospital for treatment.

In just one and a half months, more than 20,000 Danish cancer patients were injected with cancer gene editing drugs. The cancer cells in 98% of the patients decreased to 5%-20%, and a large number of cancer cells were killed and their physical condition improved!

Even acute leukemia, a very stubborn and difficult-to-treat disease, was effectively inhibited. A large number of proliferating and out-of-control leukocytes were eliminated by foreign immune weapons injected into the body, maintaining the white blood cells in the patient's body between a slightly normal index.

After that, as long as blood transfusion treatment is combined, the infinite proliferation of white blood cells can be effectively controlled.

However, the treatment of symptoms but not root causes is not the treatment. The best treatment for patients with leukemia is bone marrow transplantation.

However, the emergence of gene editing drugs has greatly extended the survival time for leukemia patients to fight against the disease, allowing them to have more time to wait for the transplantable bone marrow to appear!

In the past, if acute leukemia is not treated, the survival period will be only three months. If you actively receive treatment, some high-risk groups will have only 2-3 years of survival.

Now that I have received the treatment of gene editing drugs, a five-year and ten-year survival period is nothing. Actively cooperate with the treatment, and the survival period of more than ten or even twenty years is hopeless!

The best treatment effect is early cancer patients. Most early cancer patients, whether it is lung cancer, bronchial cancer, liver cancer and gastric cancer, and the treatment of surgery and gene editing drugs, can achieve clinical cure at all.

The recurrence rate within five years is very low, and there is a 90% survival rate in ten years.

In other words, early cancer patients can basically ensure a 10-year survival period, and ten years later, it does not mean that they will die of illness. It is just that the recurrence rate increases. Even if the cancer cells relapse again, it will activate the immune genome left in the body. They will respond quickly and inhibit the growth of cancer cells.

Some cancers that cannot be removed will be injected into the body with an immune genome that will play a role in inhibiting cancer cells for a long time, and survival with tumors will become the norm for future cancer patients!

This kind of tumor-resistant survival will basically not have any impact on the body, just like a chronic disease. Perhaps lung cancer patients will cough frequently, and gastric cancer patients may occasionally suffer from stomach pain and need to take some conditioning medication frequently, but daily life can continue!

There is no need to have frequent radiotherapy and chemotherapy, no need to lie on the hospital bed, and you can also return to a level close to that of a normal person!

This is enough to excite cancer patients! It’s like a miracle!

This is a happy event for cancer patients in Denmark, because under the arrangement of the government, they have almost all received gene editing drugs. Patients who were treated earlier have even recovered their health and returned to their jobs!

At most, after dinner and after work, I remembered the ups and downs of this experience after the diagnosis of cancer, and added some topics to myself.

But after the news flew out of Denmark, it caused a sensation around the world!

Good guy, everyone is still worried about cancer. The United States has just made some achievements in car-t cell cancer treatment, and it is still a long way from clinical practice.

What you, in Denmark, have you quietly launched gene editing drugs developed based on Crispr/cas9 gene programming technology?

And have achieved very successful clinical results?

Didn't you, a Danish guy with thick eyebrows and big eyes, have such a big news behind his back?

As a result, after a closer look, we found out that why is it the fucking Ruikang Medical???

Ruikang Medical's cardiomyocyte healing agent has just been on the market for less than a year worldwide. Why did this guy get another gene editing drug?

And why, as a Chinese medical company, Ruikang Medical’s new product was first launched in Denmark?

A series of questions have appeared in the hearts of major medical institutions, pharmaceutical companies, and related medical practitioners around the world.

After that, medical companies from various countries mobilized their connections to Denmark and China. After collecting a wave of information, they found out the whole story.

It turns out that Ruikang Medical's gene editing drugs were first tested in China, and more than 1,000 clinical trials were conducted, and the data obtained were also very good. However, the Chinese government has not passed the market approval due to various risks.

That's why Ruikang Medical applied for a second clinical trial in Denmark and passed the Danish government's approval, and was successfully launched in Denmark.

After understanding the causes and consequences, the first thing medical departments in various countries wanted to know is whether the effect of this gene editing drug is really as good as that reported by Danish media.

If everything is true, then even if this is a drug born based on gene editing technology, they will definitely go against the public's opinions!

Including America!

Because the global base of cancer patients is really too large!

The number of new cancer patients that are detected every year and recorded is more than 20 million, which has increased to 25 million last year, and the death toll is more than 9 million every year!

No country or region will ignore this set of data!

Moreover, Ruikang's gene editing drug is different from cardiomyocyte healing agents, and this drug has no competitors!

The emergence of cardiomyocyte healing agents has greatly hit the market of traditional mechanical pacemakers, and this market has billions of dollars in profits every year. Various stakeholder organizations and individuals will naturally stand from the perspective of interests and block the launch of cardiomyocyte healing agents.

Different cancer gene editing drugs, this drug is considered a special targeted drug, although it has invaded the market for some cancer targeted drugs to a certain extent.

However, drugs are different from medical equipment. Drugs often need to be used together. Even if the patient uses gene editing drugs, they can also be used with other targeted drugs, which can provide better treatment for eliminating cancer!

Two drugs can be done in two ways, and cooperation is greater than competition!

Since gene editing drugs do not infringe on any existing pharmaceutical market, medical institutions and relevant departments in various countries naturally warmly welcome the emergence of this new type of cancer treatment drug!

However, when the four words "gene editing" spread all over the world with the launch of cancer gene editing drugs.

A group of so-called "knowledgeable people" could not suppress their concern for the country and the people, and jumped up and down...
Chapter completed!